AGP Executive Report
Last update: 10 hours agoCorporate Finance & Crypto: Akamai in Cambridge expanded its AI partnership with Anthropic in a deal worth $11.6 billion over seven years, positioning the company as infrastructure for “responsible AI.” Biotech & Clinical Trials: Lantheus said the first patient was dosed in its SPARROW Phase 2/3 prostate cancer PET trial, while Oryzon won EMA authorization to start HOPE-2 for Phelan-McDermid syndrome and Tiziana Life Sciences dosed the first participants in an intranasal foralumab ALS study. Healthcare Workforce: Laudio and AONL reported that nurses who earn a clinical ladder level in their first year show a 91% two-year retention rate, with participation benefits strongest right after ladder achievement. Energy & Research Policy: A new study says Trump-era attacks on university autonomy have increased outside influence over climate and energy research, potentially reshaping what questions get asked. Local Business & Community: Arlington libraries created jigsaw puzzles using historic Black community photos to bring segregation-era recreation history to kids. Storm Impacts: A nor’easter continued to flood and knock out power across the Northeast, with officials warning of additional high-tide flooding.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
